Condition: Inoperable œsophageal Cancer
Interventions: Drug: Nivolumab; Drug: Ipilimumab; Other: Chemoradiation
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Not yet recruiting
http://ift.tt/2GreItE
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: June 2018 Source: Acta Biomaterialia, Volume 73 https://ift.tt/2kBbISt
-
http://bit.ly/2SylJiJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου